It is a pharma public limited company based in Delhi, Delhi, India, established in 2012.
2012 | Delhi, Delhi, India | ActiveAvrohn Pharma (I) Limited, a active public limited company, was established on 12 March 2012 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24119DL2012PLC232680. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Neeta Verender Kumar Gupta (Director), Virender Kumar Gupta (Director), Abhishek Gupta (Director). Past directors included Garima Jain. It holds ₹3.02 Cr open charges and ₹6.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at G-216, Hall No. 1, Ground Floor, Dakka Village, Near Kingsway Camp,, Delhi, Delhi, 110009.
U24119DL2012PLC232680
232680
12 March 2012
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Avrohn Pharma (I) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeta Verender Kumar Gupta | Director | 26 Mar 2022 | Current |
| Virender Kumar Gupta | Director | 12 Mar 2012 | Current |
| Abhishek Gupta | Director | 12 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avrohn Pharma (I) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.98% increase. The company also saw a slight improvement in profitability, with a 5.88% increase in profit. The company's net worth Soared by an impressive increase of 32.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Avrohn Pharma (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,227,000.00
₹6,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2025 | Others | ₹2.50 M | Open |
| 11 Mar 2025 | Canara Bank | ₹2.93 M | Open |
| 06 Feb 2024 | Canara Bank | ₹1.90 M | Open |
| 06 Nov 2023 | Canara Bank | ₹1.95 Cr | Open |
| 19 Oct 2019 | Canara Bank | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Avrohn Pharma (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avrohn Pharma (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avrohn Pharma (I)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Avrohn Pharma (I) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 2.50 M with Charge ID 101109968 was registered on 17 Jun 2025. was recorded as a recent event.
The activity Avrohn Pharma (I) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
A charge with Canara Bank amounted to Rs. 2.93 M with Charge ID 101064316 was registered on 11 Mar 2025. was recorded as a recent event.
The activity A charge registered on 28 Sep 2022 via Charge ID 100676073 with Hdfc Bank Limited was fully satisfied on 24 Sep 2024. was completed.
A charge with Canara Bank of Rs. 19.50 M registered on 06 Nov 2023 with Charge ID 100817488 was modified on 10 Sep 2024. was recorded as a recent event.
The CIN of Avrohn Pharma (I) Limited is U24119DL2012PLC232680.
Avrohn Pharma (I) Limited is headquartered at G-216, Hall No. 1, Ground Floor, Dakka Village, Near Kingsway Camp,, Delhi, Delhi, 110009.
Avrohn Pharma (I) Limited was incorporated on 12 March 2012.
The current directors of Avrohn Pharma (I) Limited are
The primary industry of Avrohn Pharma (I) Limited is Trade.
Avrohn Pharma (I) Limited is unlisted.
The authorized capital of Avrohn Pharma (I) Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Avrohn Pharma (I) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX